{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:11:15Z","timestamp":1771953075465,"version":"3.50.1"},"reference-count":41,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Loss-of-function mutations and deletions in the core components of the epigenetic polycomb repressive complex 2 (PRC2) are associated with poor initial treatment response in T-cell acute lymphoblastic leukemia (T-ALL), but the mechanisms that underpin resistance to individual therapies are unknown. We leveraged an isogenic T-ALL cellular model and primary patient data to investigate how PRC2 alterations affect signaling pathway activity in leukemia cells, and whether these changes may influence therapy response. The integration of transcriptomic, proteomic, and phosphoproteomic results revealed markedly reduced activity of the WNT-dependent stabilization of proteins (WNT\/STOP) pathway in leukemia cells lacking core PRC2 factor EZH2. Importantly, these results closely matched transcriptional readouts from the samples of patients with T-ALL with PRC2 mutations and deletions. We discovered that PRC2 loss significantly reduced sensitivity to key T-ALL treatment asparaginase, and that this was mechanistically linked to increased cellular ubiquitination levels due to WNT\/STOP suppression, which bolstered the asparagine reserves of leukemia cells. These results also strongly correlated with transcriptional profiles of asparaginase resistance in an independent cohort of patients with T-ALL. We further found that asparaginase resistance in PRC2-depleted leukemic blasts could be mitigated by pharmaceutical proteasome inhibition, thereby providing a potential avenue to tackle induction treatment failure in these cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015408","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T21:00:36Z","timestamp":1764795636000},"page":"1301-1311","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activity"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2689-8175","authenticated-orcid":false,"given":"Thomas","family":"Lefeivre","sequence":"first","affiliation":[{"name":"1Systems Biology Ireland, University College Dublin, Dublin, Ireland"},{"name":"2School of Medicine, University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4254-831X","authenticated-orcid":false,"given":"Theodora-Ioana","family":"Grosu","sequence":"additional","affiliation":[{"name":"1Systems Biology Ireland, University College Dublin, Dublin, Ireland"},{"name":"2School of Medicine, University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9314-9108","authenticated-orcid":false,"given":"Cosmin","family":"Tudose","sequence":"additional","affiliation":[{"name":"1Systems Biology Ireland, University College Dublin, Dublin, Ireland"},{"name":"2School of Medicine, University College Dublin, Dublin, Ireland"},{"name":"3Research Ireland Centre for Research Training in Genomics Data Science, Galway, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Jones","sequence":"additional","affiliation":[{"name":"1Systems Biology Ireland, University College Dublin, Dublin, Ireland"},{"name":"2School of Medicine, University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa E.","family":"Le\u00f3n","sequence":"additional","affiliation":[{"name":"4Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5759-5285","authenticated-orcid":false,"given":"Kieran","family":"Wynne","sequence":"additional","affiliation":[{"name":"1Systems Biology Ireland, University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Oliviero","sequence":"additional","affiliation":[{"name":"1Systems Biology Ireland, University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen P.","family":"Smith","sequence":"additional","affiliation":[{"name":"1Systems Biology Ireland, University College Dublin, Dublin, Ireland"},{"name":"2School of Medicine, University College Dublin, Dublin, Ireland"},{"name":"5University of Dublin, Trinity College, Dublin, Ireland"},{"name":"6National Children\u2019s Cancer Service, Children\u2019s Health Ireland at Crumlin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4598-9358","authenticated-orcid":false,"given":"Am\u00e9lie","family":"Trinquand","sequence":"additional","affiliation":[{"name":"6National Children\u2019s Cancer Service, Children\u2019s Health Ireland at Crumlin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6835-3791","authenticated-orcid":false,"given":"Marc R.","family":"Mansour","sequence":"additional","affiliation":[{"name":"4Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom"},{"name":"7Division of Developmental Biology and Cancer, Great Ormond Street Institute of Child Health, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2750-9854","authenticated-orcid":false,"given":"Colm J.","family":"Ryan","sequence":"additional","affiliation":[{"name":"1Systems Biology Ireland, University College Dublin, Dublin, Ireland"},{"name":"2School of Medicine, University College Dublin, Dublin, Ireland"},{"name":"8Conway Institute, University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7636-1599","authenticated-orcid":false,"given":"Jonathan","family":"Bond","sequence":"additional","affiliation":[{"name":"1Systems Biology Ireland, University College Dublin, Dublin, Ireland"},{"name":"2School of Medicine, University College Dublin, Dublin, Ireland"},{"name":"6National Children\u2019s Cancer Service, Children\u2019s Health Ireland at Crumlin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"3","key":"2026022411382911300_bib1","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/S1470-2045(19)30031-2","article-title":"Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia","volume":"20","author":"Teachey","year":"2019","journal-title":"Lancet Oncol"},{"issue":"7380","key":"2026022411382911300_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"issue":"8","key":"2026022411382911300_bib3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"issue":"23","key":"2026022411382911300_bib4","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1200\/JCO.2016.71.8585","article-title":"Early response-based therapy stratification improves survival in adult early thymic precursor acute lymphoblastic leukemia: a group for research on adult acute lymphoblastic leukemia study","volume":"35","author":"Bond","year":"2017","journal-title":"J Clin Oncol"},{"issue":"8027","key":"2026022411382911300_bib5","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","article-title":"The genomic basis of childhood T-lineage acute lymphoblastic leukaemia","volume":"632","author":"P\u00f6l\u00f6nen","year":"2024","journal-title":"Nature"},{"issue":"6","key":"2026022411382911300_bib6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1200\/JCO.2016.69.6278","article-title":"Use of minimal residual disease assessment to redefine induction failure in pediatric acute lymphoblastic leukemia","volume":"35","author":"O'Connor","year":"2017","journal-title":"J Clin Oncol"},{"issue":"8","key":"2026022411382911300_bib7","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/s41375-018-0187-9","article-title":"Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemia","volume":"32","author":"Bond","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"2026022411382911300_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nm.4247","article-title":"Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia","volume":"23","author":"G\u00f6llner","year":"2017","journal-title":"Nat Med"},{"issue":"2","key":"2026022411382911300_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.2651","article-title":"Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia","volume":"18","author":"Ntziachristos","year":"2012","journal-title":"Nat Med"},{"issue":"12","key":"2026022411382911300_bib10","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1084\/jem.20180570","article-title":"PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia","volume":"215","author":"Ari\u00ebs","year":"2018","journal-title":"J Exp Med"},{"issue":"10","key":"2026022411382911300_bib11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3324\/haematol.2015.130179","article-title":"Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia","volume":"100","author":"Vicente","year":"2015","journal-title":"Haematologica"},{"issue":"5","key":"2026022411382911300_bib12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/2159-8290.CD-17-0583","article-title":"HOXA9 cooperates with activated JAK\/STAT signaling to drive leukemia development","volume":"8","author":"de Bock","year":"2018","journal-title":"Cancer Discov"},{"issue":"12","key":"2026022411382911300_bib13","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1038\/s41375-022-01716-9","article-title":"JAK\/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL","volume":"36","author":"Benyoucef","year":"2022","journal-title":"Leukemia"},{"issue":"2","key":"2026022411382911300_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1158\/2643-3230.BCD-21-0115","article-title":"BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PRC1.1 from target genes","volume":"3","author":"Schaefer","year":"2022","journal-title":"Blood Cancer Discov"},{"issue":"4","key":"2026022411382911300_bib15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ccell.2019.03.004","article-title":"Synthetic lethality of Wnt pathway activation and asparaginase in drug-resistant acute leukemias","volume":"35","author":"Hinze","year":"2019","journal-title":"Cancer Cell"},{"issue":"11","key":"2026022411382911300_bib16","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1158\/2159-8290.CD-19-1472","article-title":"Exploiting the therapeutic interaction of WNT pathway activation and asparaginase for colorectal cancer therapy","volume":"10","author":"Hinze","year":"2020","journal-title":"Cancer Discov"},{"issue":"15","key":"2026022411382911300_bib17","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1016\/j.molcel.2022.05.025","article-title":"Supramolecular assembly of GSK3\u03b1 as a cellular response to amino acid starvation","volume":"82","author":"Hinze","year":"2022","journal-title":"Mol Cell"},{"issue":"1","key":"2026022411382911300_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","article-title":"Perturbation-response genes reveal signaling footprints in cancer gene expression","volume":"9","author":"Schubert","year":"2018","journal-title":"Nat Commun"},{"issue":"21","key":"2026022411382911300_bib19","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1093\/bioinformatics\/btx415","article-title":"The KSEA app: a web-based tool for kinase activity inference from quantitative phosphoproteomics","volume":"33","author":"Wiredja","year":"2017","journal-title":"Bioinformatics"},{"issue":"1","key":"2026022411382911300_bib20","doi-asserted-by":"crossref","first-page":"18211","DOI":"10.1038\/s41598-022-22885-8","article-title":"Wildtype heterogeneity contributes to clonal variability in genome edited cells","volume":"12","author":"Westermann","year":"2022","journal-title":"Sci Rep"},{"issue":"7","key":"2026022411382911300_bib21","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-19-0789","article-title":"EZH2-deficient T-cell acute lymphoblastic leukemia is sensitized to CHK1 inhibition through enhanced replication stress","volume":"10","author":"Le\u00f3n","year":"2020","journal-title":"Cancer Discov"},{"issue":"7945","key":"2026022411382911300_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41586-022-05575-3","article-title":"An atlas of substrate specificities for the human serine\/threonine kinome","volume":"613","author":"Johnson","year":"2023","journal-title":"Nature"},{"issue":"11","key":"2026022411382911300_bib23","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.bjc.6603447","article-title":"Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines","volume":"95","author":"Beesley","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"2026022411382911300_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41591-022-02112-7","article-title":"Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response","volume":"29","author":"Lee","year":"2023","journal-title":"Nat Med"},{"issue":"18","key":"2026022411382911300_bib25","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1073\/pnas.1423533112","article-title":"Maternal Wnt\/STOP signaling promotes cell division during early Xenopus embryogenesis","volume":"112","author":"Huang","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2026022411382911300_bib26","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2010.11.034","article-title":"Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes","volume":"143","author":"Taelman","year":"2010","journal-title":"Cell"},{"issue":"11","key":"2026022411382911300_bib27","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2014-06-580480","article-title":"Efficacy of JAK\/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"},{"issue":"28","key":"2026022411382911300_bib28","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1200\/JCO.2005.11.411","article-title":"Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia","volume":"23","author":"Pession","year":"2005","journal-title":"J Clin Oncol"},{"issue":"17","key":"2026022411382911300_bib29","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1200\/JCO.19.03024","article-title":"Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"38","author":"Gupta","year":"2020","journal-title":"J Clin Oncol"},{"key":"2026022411382911300_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejca.2021.08.025","article-title":"How much asparaginase is needed for optimal outcome in childhood acute lymphoblastic leukaemia? A systematic review","volume":"157","author":"Brigitha","year":"2021","journal-title":"Eur J Cancer"},{"issue":"10","key":"2026022411382911300_bib31","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/0006-2952(69)90375-X","article-title":"l-asparaginase resistance in human leukemia--asparagine synthetase","volume":"18","author":"Haskell","year":"1969","journal-title":"Biochem Pharmacol"},{"issue":"3827","key":"2026022411382911300_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.160.3827.533","article-title":"Asparagine synthetase activity of mouse leukemias","volume":"160","author":"Horowitz","year":"1968","journal-title":"Science"},{"issue":"8","key":"2026022411382911300_bib33","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1158\/1078-0432.CCR-18-1844","article-title":"Epigenetic silencing affects l-asparaginase sensitivity and predicts outcome in T-ALL","volume":"25","author":"Touzart","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2026022411382911300_bib34","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1182\/blood-2002-08-2446","article-title":"Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL","volume":"101","author":"Stams","year":"2003","journal-title":"Blood"},{"issue":"6","key":"2026022411382911300_bib35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa033513","article-title":"Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment","volume":"351","author":"Holleman","year":"2004","journal-title":"N Engl J Med"},{"issue":"11","key":"2026022411382911300_bib36","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1182\/blood-2005-06-2597","article-title":"Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia","volume":"107","author":"Appel","year":"2006","journal-title":"Blood"},{"issue":"1","key":"2026022411382911300_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cell.2017.08.002","article-title":"Genome regulation by polycomb and trithorax: 70 years and counting","volume":"171","author":"Schuettengruber","year":"2017","journal-title":"Cell"},{"issue":"11","key":"2026022411382911300_bib38","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrm4067","article-title":"Targeting Polycomb systems to regulate gene expression: modifications to a complex story","volume":"16","author":"Blackledge","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"2026022411382911300_bib39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nsmb.2669","article-title":"Transcriptional regulation by Polycomb group proteins","volume":"20","author":"Di Croce","year":"2013","journal-title":"Nat Struct Mol Biol"},{"issue":"33","key":"2026022411382911300_bib40","doi-asserted-by":"crossref","first-page":"e2303010120","DOI":"10.1073\/pnas.2303010120","article-title":"Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways","volume":"120","author":"Liu","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"2026022411382911300_bib41","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1073\/pnas.1000031107","article-title":"Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/4\/1301\/2503906\/blooda_adv-2024-015408-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/4\/1301\/2503906\/blooda_adv-2024-015408-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:38:39Z","timestamp":1771951119000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/4\/1301\/556934\/Reduced-PRC2-function-causes-asparaginase"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015408","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,24]]},"published":{"date-parts":[[2026,2,13]]}}}